Cargando…
Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
BACKGROUND: Diverse aberrancy in genetic background, protein profiling, and biological pathways have emerged as important factors hindering discovery of effective treatment of osteosarcoma. In a previous study, we used a proteomic approach to identify some osteosarcoma-related proteins by analysis o...
Autores principales: | Chaiyawat, Parunya, Pruksakorn, Dumnoensun, Pipatwattana, Prach, Phanphaisarn, Areerak, Teeyakasem, Pimpisa, Klangjorhor, Jeerawan, Settakorn, Jongkolnee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444297/ https://www.ncbi.nlm.nih.gov/pubmed/30984555 http://dx.doi.org/10.1016/j.jbo.2019.100233 |
Ejemplares similares
-
Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications
por: Chaiyawat, Parunya, et al.
Publicado: (2018) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2017) -
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2020) -
IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2021) -
Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2017)